Accordingly, our group also reported increased levels of TNFR2 in patients with decreased eGFR and suggested their potential as a biomarker of early CKD, as well as disease staging/worsening in a cohort of CKD patients with diverse etiologies [14]. This evidence concerns the gene TNFRSF1B and chronic kidney disease.